153 related articles for article (PubMed ID: 8094626)
1. Expressions of DNA topoisomerase I and II gene and the genes possibly related to drug resistance in human myeloma cells.
Ishikawa H; Kawano MM; Okada K; Tanaka H; Tanabe O; Sakai A; Asaoku H; Iwato K; Nobuyoshi M; Kuramoto A
Br J Haematol; 1993 Jan; 83(1):68-74. PubMed ID: 8094626
[TBL] [Abstract][Full Text] [Related]
2. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
3. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
4. Factors contributing to adriamycin sensitivity in human xenograft tumors: the relationship between expression of the MDR1, GST-pi and topoisomerase II genes and tumor sensitivity to adriamycin.
Kim R; Hirabayashi N; Nishiyama M; Jinushi K; Toge T; Okada K
Anticancer Res; 1992; 12(1):241-5. PubMed ID: 1314532
[TBL] [Abstract][Full Text] [Related]
5. Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin.
Kim R; Hirabayashi N; Nishiyama M; Saeki S; Toge T; Okada K
Anticancer Res; 1991; 11(1):429-31. PubMed ID: 1850221
[TBL] [Abstract][Full Text] [Related]
6. Expression of drug resistance-associated mdr-1, GST pi, and topoisomerase II genes during cell cycle traverse.
Ramachandran C; Mead D; Wellham LL; Sauerteig A; Krishan A
Biochem Pharmacol; 1995 Feb; 49(4):545-52. PubMed ID: 7872960
[TBL] [Abstract][Full Text] [Related]
7. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
8. Expression of multidrug resistance-related genes (mdrl, MRP, GST-pi and DNA topoisomerase II) in urothelial cancers.
Kim WJ; Kakehi Y; Wu WJ; Fukumoto M; Yoshida O
Br J Urol; 1996 Sep; 78(3):361-8. PubMed ID: 8881943
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein but not topoisomerase II and glutathione-S-transferase-pi accounts for enhanced intracellular drug-resistance in LoVo MDR human cell lines.
Boiocchi M; Tumiotto L; Giannini F; Viel A; Biscontin G; Sartor F; Toffoli G
Tumori; 1992 Jun; 78(3):159-66. PubMed ID: 1359686
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors.
Efferth T; Mattern J; Volm M
Oncology; 1992; 49(5):368-75. PubMed ID: 1356260
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance.
Yu DS; Ma CP; Chang SY
Urol Res; 2000 Apr; 28(2):86-92. PubMed ID: 10850629
[TBL] [Abstract][Full Text] [Related]
13. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
14. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
Lefevre D; Riou JF; Ahomadegbe JC; Zhou DY; Benard J; Riou G
Biochem Pharmacol; 1991 Jun; 41(12):1967-79. PubMed ID: 1645555
[TBL] [Abstract][Full Text] [Related]
15. Expression of resistance-related proteins in nephroblastoma after chemotherapy.
Volm M; Mattern J; Stammler G; Royer-Pokora B; Schneider S; Weirich A; Ludwig R
Int J Cancer; 1995 Oct; 63(2):193-7. PubMed ID: 7591203
[TBL] [Abstract][Full Text] [Related]
16. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
17. HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.
Zwelling LA; Slovak ML; Doroshow JH; Hinds M; Chan D; Parker E; Mayes J; Sie KL; Meltzer PS; Trent JM
J Natl Cancer Inst; 1990 Oct; 82(19):1553-61. PubMed ID: 1976136
[TBL] [Abstract][Full Text] [Related]
18. Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myeloma.
Linsenmeyer ME; Jefferson S; Wolf M; Matthews JP; Board PG; Woodcock DM
Br J Cancer; 1992 Mar; 65(3):471-5. PubMed ID: 1348425
[TBL] [Abstract][Full Text] [Related]
19. Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer.
Codegoni AM; Broggini M; Pitelli MR; Pantarotto M; Torri V; Mangioni C; D'Incalci M
Gynecol Oncol; 1997 Apr; 65(1):130-7. PubMed ID: 9103402
[TBL] [Abstract][Full Text] [Related]
20. Different sensitivities of human esophageal cancer cells to multiple anti-cancer agents and related mechanisms.
Saito T; Hikita M; Kohno K; Sato S; Takano H; Kobayashi M
Cancer; 1992 Nov; 70(10):2402-9. PubMed ID: 1358426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
